Các yếu tố phiên mã FoxO động học

Journal of Cell Science - Tập 120 Số 15 - Trang 2479-2487 - 2007
Haojie Huang1, Donald J. Tindall2
1Cancer Center and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA
2Departments of Urology and Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA

Tóm tắt

Các yếu tố phiên mã hộp Forkhead O (FoxO) bao gồm FoxO1, FoxO3a, FoxO4 và FoxO6, là các đồng loại động vật có vú của DAF-16 ở Caenorhabditis elegans, đang nổi lên như một họ protein quan trọng điều chỉnh biểu hiện của các gen liên quan đến apoptosis, chu kỳ tế bào, sửa chữa DNA, căng thẳng oxy hóa, phân hóa tế bào, chuyển hóa glucose và các chức năng tế bào khác. Các protein FoxO được điều chỉnh bởi nhiều cơ chế khác nhau. Chúng trải qua phosphoryl hóa ức chế bởi các kinase protein như Akt, SGK, IKK và CDK2 dưới tác động của các kích thích bên ngoài và bên trong. Ngược lại, chúng được kích hoạt bởi các yếu tố điều hòa thượng nguồn như JNK và MST1 trong điều kiện căng thẳng. Hoạt động của chúng được cân bằng bởi các acetylase CBP và p300 cùng với deacetylase SIRT1. Hơn nữa, trong khi polyubiquitylation của FoxO1 và FoxO3a dẫn đến sự phân hủy của chúng bởi proteasome, monoubiquitylation của FoxO4 lại tạo điều kiện cho sự định vị trong nhân và tăng cường hoạt động phiên mã của nó. Do đó, các chức năng mạnh mẽ của các protein FoxO được kiểm soát chặt chẽ bởi các con đường tín hiệu phức tạp trong các điều kiện sinh lý; sự điều hòa bất thường của các protein này có thể dẫn đến bệnh tật như ung thư.

Từ khóa


Tài liệu tham khảo

Accili, D. and Arden, K. C. (2004). FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell117, 421-426.

Ahn, S. H., Cheung, W. L., Hsu, J. Y., Diaz, R. L., Smith, M. M. and Allis, C. D. (2005). Sterile 20 kinase phosphorylates histone H2B at serine 10 during hydrogen peroxide-induced apoptosis in S. cerevisiae. Cell120, 25-36.

Alessi, D. R., Caudwell, F. B., Andjelkovic, M., Hemmings, B. A. and Cohen, P. (1996). Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett.399, 333-338.

Alvarez, B., Martinez, A. C., Burgering, B. M. and Carrera, A. C. (2001). Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature413, 744-747.

Anderson, M. J., Viars, C. S., Czekay, S., Cavenee, W. K. and Arden, K. C. (1998). Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics47, 187-199.

Andjelkovic, M., Alessi, D. R., Meier, R., Fernandez, A., Lamb, N. J., Frech, M., Cron, P., Cohen, P., Lucocq, J. M. and Hemmings, B. A. (1997). Role of translocation in the activation and function of protein kinase B. J. Biol. Chem.272, 31515-31524.

Aoki, M., Jiang, H. and Vogt, P. K. (2004). Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc. Natl. Acad. Sci. USA101, 13613-13617.

Balaban, R. S., Nemoto, S. and Finkel, T. (2005). Mitochondria, oxidants, and aging. Cell120, 483-495.

Baron, S., Manin, M., Beaudoin, C., Leotoing, L., Communal, Y., Veyssiere, G. and Morel, L. (2004). Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J. Biol. Chem.279, 14579-14586.

Barthel, A., Schmoll, D. and Unterman, T. G. (2005). FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab.16, 183-189.

Bashir, T., Dorrello, N. V., Amador, V., Guardavaccaro, D. and Pagano, M. (2004). Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature428, 190-193.

Biggs, W. H., 3rd, Meisenhelder, J., Hunter, T., Cavenee, W. K. and Arden, K. C. (1999). Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA96, 7421-7426.

Bois, P. R., Izeradjene, K., Houghton, P. J., Cleveland, J. L., Houghton, J. A. and Grosveld, G. C. (2005). FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma. J. Cell Biol.170, 903-912.

Borkhardt, A., Repp, R., Haas, O. A., Leis, T., Harbott, J., Kreuder, J., Hammermann, J., Henn, T. and Lampert, F. (1997). Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene14, 195-202.

Boura, E., Silhan, J., Herman, P., Vecer, J., Sulc, M., Teisinger, J., Obsilova, V. and Obsil, T. (2007). Both the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA binding. J. Biol. Chem.282, 8265-8275.

Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell96, 857-868.

Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A. and Greenberg, M. E. (2001). Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol.21, 952-965.

Brunet, A., Kanai, F., Stehn, J., Xu, J., Sarbassova, D., Frangioni, J. V., Dalal, S. N., DeCaprio, J. A., Greenberg, M. E. and Yaffe, M. B. (2002). 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol.156, 817-828.

Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y. et al. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science303, 2011-2015.

Clark, K. L., Halay, E. D., Lai, E. and Burley, S. K. (1993). Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature364, 412-420.

Corral, J., Forster, A., Thompson, S., Lampert, F., Kaneko, Y., Slater, R., Kroes, W. G., van der Schoot, C. E., Ludwig, W. D., Karpas, A. et al. (1993). Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc. Natl. Acad. Sci. USA90, 8538-8542.

Daitoku, H., Hatta, M., Matsuzaki, H., Aratani, S., Ohshima, T., Miyagishi, M., Nakajima, T. and Fukamizu, A. (2004). Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl. Acad. Sci. USA101, 10042-10047.

DeVol, D. L., Rotwein, P., Sadow, J. L., Novakofski, J. and Bechtel, P. J. (1990). Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am. J. Physiol.259, E89-E95.

Dijkers, P. F., Medema, R. H., Lammers, J. W., Koenderman, L. and Coffer, P. J. (2000a). Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol.10, 1201-1204.

Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S., Lam, E. W., Burgering, B. M., Raaijmakers, J. A., Lammers, J. W., Koenderman, L. et al. (2000b). Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol. Cell. Biol.20, 9138-9148.

Essers, M. A., Weijzen, S., de Vries-Smits, A. M., Saarloos, I., de Ruiter, N. D., Bos, J. L. and Burgering, B. M. (2004). FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J.23, 4802-4812.

Essers, M. A., de Vries-Smits, L. M., Barker, N., Polderman, P. E., Burgering, B. M. and Korswagen, H. C. (2005). Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science308, 1181-1184.

Fernandez de Mattos, S., Essafi, A., Soeiro, I., Pietersen, A. M., Birkenkamp, K. U., Edwards, C. S., Martino, A., Nelson, B. H., Francis, J. M., Jones, M. C. et al. (2004). FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Mol. Cell. Biol.24, 10058-10071.

Frescas, D., Valenti, L. and Accili, D. (2005). Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem.280, 20589-20595.

Furukawa-Hibi, Y., Yoshida-Araki, K., Ohta, T., Ikeda, K. and Motoyama, N. (2002). FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J. Biol. Chem.277, 26729-26732.

Furuyama, T., Nakazawa, T., Nakano, I. and Mori, N. (2000). Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J.349, 629-634.

Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J., 3rd, Emanuel, B. S., Rovera, G. and Barr, F. G. (1993). Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet.5, 230-235.

Gilley, J., Coffer, P. J. and Ham, J. (2003). FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell Biol.162, 613-622.

Graves, J. D., Gotoh, Y., Draves, K. E., Ambrose, D., Han, D. K., Wright, M., Chernoff, J., Clark, E. A. and Krebs, E. G. (1998). Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J.17, 2224-2234.

Greer, E. L. and Brunet, A. (2005). FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene24, 7410-7425.

Hillion, J., Le Coniat, M., Jonveaux, P., Berger, R. and Bernard, O. A. (1997). AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood90, 3714-3719.

Hishiya, A., Iemura, S., Natsume, T., Takayama, S., Ikeda, K. and Watanabe, K. (2006). A novel ubiquitin-binding protein ZNF216 functioning in muscle atrophy. EMBO J.25, 554-564.

Hosaka, T., Biggs, W. H., 3rd, Tieu, D., Boyer, A. D., Varki, N. M., Cavenee, W. K. and Arden, K. C. (2004). Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. USA101, 2975-2980.

Hu, M. C., Lee, D. F., Xia, W., Golfman, L. S., Ou-Yang, F., Yang, J. Y., Zou, Y., Bao, S., Hanada, N., Saso, H. et al. (2004). IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell117, 225-237.

Huang, H., Muddiman, D. C. and Tindall, D. J. (2004). Androgens negatively regulate forkhead transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer cells. J. Biol. Chem.279, 13866-13877.

Huang, H., Regan, K. M., Wang, F., Wang, D., Smith, D. I., van Deursen, J. M. and Tindall, D. J. (2005). Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. USA102, 1649-1654.

Huang, H., Regan, K. M., Lou, Z., Chen, J. and Tindall, D. J. (2006). CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science314, 294-297.

Jacobs, F. M., van der Heide, L. P., Wijchers, P. J., Burbach, J. P., Hoekman, M. F. and Smidt, M. P. (2003). FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J. Biol. Chem.278, 35959-35967.

Kaestner, K. H., Knochel, W. and Martinez, D. E. (2000). Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev.14, 142-146.

Kamei, Y., Miura, S., Suzuki, M., Kai, Y., Mizukami, J., Taniguchi, T., Mochida, K., Hata, T., Matsuda, J., Aburatani, H. et al. (2004). Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem.279, 41114-41123.

Kimura, K. D., Tissenbaum, H. A., Liu, Y. and Ruvkun, G. (1997). daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science277, 942-946.

Kitamura, Y. I., Kitamura, T., Kruse, J. P., Raum, J. C., Stein, R., Gu, W. and Accili, D. (2005). FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab.2, 153-163.

Kops, G. J., de Ruiter, N. D., De Vries-Smits, A. M., Powell, D. R., Bos, J. L. and Burgering, B. M. (1999). Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature398, 630-634.

Kops, G. J., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W., Coffer, P. J., Huang, T. T., Bos, J. L., Medema, R. H. and Burgering, B. M. (2002a). Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature419, 316-321.

Kops, G. J., Medema, R. H., Glassford, J., Essers, M. A., Dijkers, P. F., Coffer, P. J., Lam, E. W. and Burgering, B. M. (2002b). Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell. Biol.22, 2025-2036.

Langley, E., Pearson, M., Faretta, M., Bauer, U. M., Frye, R. A., Minucci, S., Pelicci, P. G. and Kouzarides, T. (2002). Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J.21, 2383-2396.

Lehtinen, M. K., Yuan, Z., Boag, P. R., Yang, Y., Villen, J., Becker, E. B., DiBacco, S., de la Iglesia, N., Gygi, S., Blackwell, T. K. et al. (2006). A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell125, 987-1001.

Li, M., Luo, J., Brooks, C. L. and Gu, W. (2002). Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem.277, 50607-50611.

Li, P., Lee, H., Guo, S., Unterman, T. G., Jenster, G. and Bai, W. (2003). AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Mol. Cell. Biol.23, 104-118.

Lin, K., Dorman, J. B., Rodan, A. and Kenyon, C. (1997). daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science278, 1319-1322.

Lin, S. J., Defossez, P. A. and Guarente, L. (2000). Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science289, 2126-2128.

Liu, D., Yang, X. and Songyang, Z. (2000). Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr. Biol.10, 1233-1236.

Mamillapalli, R., Gavrilova, N., Mihaylova, V. T., Tsvetkov, L. M., Wu, H., Zhang, H. and Sun, H. (2001). PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr. Biol.11, 263-267.

Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K. and Fukamizu, A. (2003). Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. USA100, 11285-11290.

Medema, R. H., Kops, G. J., Bos, J. L. and Burgering, B. M. (2000). AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature404, 782-787.

Mikosz, C. A., Brickley, D. R., Sharkey, M. S., Moran, T. W. and Conzen, S. D. (2001). Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J. Biol. Chem.276, 16649-16654.

Modur, V., Nagarajan, R., Evers, B. M. and Milbrandt, J. (2002). FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J. Biol. Chem.277, 47928-47937.

Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M. and Guarente, L. (2004). Mammalian SIRT1 represses forkhead transcription factors. Cell116, 551-563.

Nakamura, N., Ramaswamy, S., Vazquez, F., Signoretti, S., Loda, M. and Sellers, W. R. (2000). Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol.20, 8969-8982.

Nasrin, N., Ogg, S., Cahill, C. M., Biggs, W., Nui, S., Dore, J., Calvo, D., Shi, Y., Ruvkun, G. and Alexander-Bridges, M. C. (2000). DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells. Proc. Natl. Acad. Sci. USA97, 10412-10417.

Nemoto, S. and Finkel, T. (2002). Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science295, 2450-2452.

Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A. and Ruvkun, G. (1997). The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature389, 994-999.

Paik, J. H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. W., Carrasco, D. R. et al. (2007). FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell128, 309-323.

Parry, P., Wei, Y. and Evans, G. (1994). Cloning and characterization of the t(X;11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family. Genes Chromosomes Cancer11, 79-84.

Plas, D. R. and Thompson, C. B. (2003). Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J. Biol. Chem.278, 12361-12366.

Ramaswamy, S., Nakamura, N., Sansal, I., Bergeron, L. and Sellers, W. R. (2002). A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell2, 81-91.

Reed, S. I. (2002). Cell cycling? Check your brakes. Nat. Cell Biol.4, E199-E201.

Rena, G., Guo, S., Cichy, S. C., Unterman, T. G. and Cohen, P. (1999). Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem.274, 17179-17183.

Rena, G., Woods, Y. L., Prescott, A. R., Peggie, M., Unterman, T. G., Williams, M. R. and Cohen, P. (2002). Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J.21, 2263-2271.

Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H. and Goldberg, A. L. (2004). Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell117, 399-412.

Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L. and Spiegelman, B. M. (2006). PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. USA103, 16260-16265.

Schmidt, M., Fernandez de Mattos, S., van der Horst, A., Klompmaker, R., Kops, G. J., Lam, E. W., Burgering, B. M. and Medema, R. H. (2002). Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol. Cell. Biol.22, 7842-7852.

Seoane, J., Le, H. V., Shen, L., Anderson, S. A. and Massague, J. (2004). Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell117, 211-223.

Skurk, C., Izumiya, Y., Maatz, H., Razeghi, P., Shiojima, I., Sandri, M., Sato, K., Zeng, L., Schiekofer, S., Pimentel, D. et al. (2005). The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J. Biol. Chem.280, 20814-20823.

Stahl, M., Dijkers, P. F., Kops, G. J., Lens, S. M., Coffer, P. J., Burgering, B. M. and Medema, R. H. (2002). The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J. Immunol.168, 5024-5031.

Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D. and Glass, D. J. (2004). The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell14, 395-403.

Sunayama, J., Tsuruta, F., Masuyama, N. and Gotoh, Y. (2005). JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J. Cell Biol.170, 295-304.

Sutterluty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Muller, U. and Krek, W. (1999). p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol.1, 207-214.

Tang, E. D., Nunez, G., Barr, F. G. and Guan, K. L. (1999). Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem.274, 16741-16746.

Tissenbaum, H. A. and Guarente, L. (2001). Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature410, 227-230.

Tothova, Z., Kollipara, R., Huntly, B. J., Lee, B. H., Castrillon, D. H., Cullen, D. E., McDowell, E. P., Lazo-Kallanian, S., Williams, I. R., Sears, C. et al. (2007). FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell128, 325-339.

Tran, H., Brunet, A., Grenier, J. M., Datta, S. R., Fornace, A. J., Jr, DiStefano, P. S., Chiang, L. W. and Greenberg, M. E. (2002). DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science296, 530-534.

Van Der Heide, L. P., Hoekman, M. F. and Smidt, M. P. (2004). The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J.380, 297-309.

van der Horst, A., de Vries-Smits, A. M., Brenkman, A. B., van Triest, M. H., van den Broek, N., Colland, F., Maurice, M. M. and Burgering, B. M. (2006). FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol.8, 1064-1073.

Vaziri, H., Dessain, S. K., Ng Eaton, E., Imai, S. I., Frye, R. A., Pandita, T. K., Guarente, L. and Weinberg, R. A. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell107, 149-159.

Wang, M. C., Bohmann, D. and Jasper, H. (2005). JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell121, 115-125.

Wang, X., Gorospe, M., Huang, Y. and Holbrook, N. J. (1997). p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene15, 2991-2997.

Wei, W., Ayad, N. G., Wan, Y., Zhang, G. J., Kirschner, M. W. and Kaelin, W. G., Jr (2004). Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature428, 194-198.

Weigel, D., Jurgens, G., Kuttner, F., Seifert, E. and Jackle, H. (1989). The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell57, 645-658.

Woods, Y. L., Rena, G., Morrice, N., Barthel, A., Becker, W., Guo, S., Unterman, T. G. and Cohen, P. (2001). The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem. J.355, 597-607.

Wu, M., Bellas, R. E., Shen, J., Yang, W. and Sonenshein, G. E. (1999). Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells. J. Immunol.163, 6530-6535.

Wu, W., Zou, M., Brickley, D. R., Pew, T. and Conzen, S. D. (2006). Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells. Mol. Endocrinol.20, 2304-2314.

Xuan, Z. and Zhang, M. Q. (2005). From worm to human: bioinformatics approaches to identify FOXO target genes. Mech. Ageing Dev.126, 209-215.

Zhao, X., Gan, L., Pan, H., Kan, D., Majeski, M., Adam, S. A. and Unterman, T. G. (2004). Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem. J.378, 839-849.